Literature DB >> 8564837

A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene.

X L Wang1, A S Sim, R F Badenhop, R M McCredie, D E Wilcken.   

Abstract

Endothelium-dependent vasodilatation is mediated by release of nitric oxide formed by constitutively expressed endothelial nitric oxide synthase (ecNOS). We explored the distribution of polymorphism ecNOS4a/b in 549 subjects with, and 153 without, coronary artery disease in relation to smoking. In current and ex-cigarette smokers, but not nonsmokers, there was a significant excess of homozygotes for the rare ecNOS4a allele in patients with severely stenosed arteries, compared with those with no or mild stenosis. This genotype was also associated with a history of myocardial infarction. This smoking-dependent excess coronary risk in ecNOS4a homozygotes is consistent with predisposition to endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8564837     DOI: 10.1038/nm0196-41

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  76 in total

Review 1.  Endothelial nitric oxide in humans in health and disease.

Authors:  P Vallance; A Hingorani
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

Review 2.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

3.  Bleeding duodenal ulcer and association with polymorphism of endothelial constitutive nitric oxide synthase gene.

Authors:  Trinidad Serrano; Elena Piazuelo; Rafael Benito; Santos Santolaria; Angel Lanas
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

Review 4.  Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental links.

Authors:  R D Rudic; W C Sessa
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

5.  Endothelial nitric oxide synthase gene intron 4 a/b VNTR polymorphism in children with APSGN.

Authors:  Hasan Dursun; Aytul Noyan; Selcuk Matyar; Mithat Buyukcelik; Mustafa Soran; Nurcan Cengiz; Gulsah Seydaoglu; Gulen Attila; Aysun K Bayazit; Ali Anarat
Journal:  Pediatr Nephrol       Date:  2006-08-29       Impact factor: 3.714

6.  Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Craig R Lee; Kari E North; Molly S Bray; Myriam Fornage; John M Seubert; John W Newman; Bruce D Hammock; David J Couper; Gerardo Heiss; Darryl C Zeldin
Journal:  Hum Mol Genet       Date:  2006-04-04       Impact factor: 6.150

7.  Application of machine learning algorithms to predict coronary artery calcification with a sibship-based design.

Authors:  Yan V Sun; Lawrence F Bielak; Patricia A Peyser; Stephen T Turner; Patrick F Sheedy; Eric Boerwinkle; Sharon L R Kardia
Journal:  Genet Epidemiol       Date:  2008-05       Impact factor: 2.135

8.  Genotype-dependent expression of endothelial nitric oxide synthase (eNOS) and its regulatory proteins in cultured endothelial cells.

Authors:  Duraisamy Senthil; Muthuswamy Raveendran; Ying H Shen; Budi Utama; Donald Dudley; Jian Wang; Xing Li Wang
Journal:  DNA Cell Biol       Date:  2005-04       Impact factor: 3.311

Review 9.  Nitric oxide in the human cardiovascular system--SKB lecture 1997.

Authors:  P Vallance
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

10.  Endothelial nitric oxide synthase genotype modulates the improvement of coronary blood flow by pravastatin: a placebo-controlled PET study.

Authors:  Tarja A Kunnas; Terho Lehtimäki; Reijo Laaksonen; Erkki Ilveskoski; Tuula Janatuinen; Risto Vesalainen; Pirjo Nuutila; Pekka J Karhunen; Juhani Knuuti; Seppo T Nikkari
Journal:  J Mol Med (Berl)       Date:  2002-11-22       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.